GRP logo
Good Research Practices For Cost-Effectiveness Analysis Alongside Clinical Trials

Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report

The authors have updated this 2005 task force report. Please see: Cost-Effectiveness Analysis Alongside Clinical Trials II Good Research Practices

The citation for this report is:
Ramsey SD, Wilke RJ, Briggs AH, et al.  Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report. Value Health 2005; 8:521-33.

Translations:
» Русский | » Български

Leadership Group:
Scott Ramsey, MD, PhD, Task Force Co-Chair, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Richard Willke, PhD, Task Force Co-Chair, Pfizer, Inc., Bridgewater, NJ, USA
Andrew Briggs, DPhil, University of Oxford, Health Economics Research Center, Headington, Oxford, UK
Ruth Brow, MS, MEDTAP International, London, UK
Martin Buxton, PhD, Brunel University, Uxbridge, Middlesex, UK
Anita Chawla, PhD, Genentech, San Francisco, CA, USA
John Cook, PhD, Merck Research Laboratories, Blue Bell, PA, USA
Henry Glick, PhD, University of Pennsylvania, Division of Internal Medicine, Philadelphia, PA, USA
Bengt Lilja, PhD, AstraZeneca, Lund, Sweden
Diana Petitti, MD, Kaiser Permanente, Pasadena, CA, USA
Shelby Reed, PhD, Duke Clinical Research Institute, Durham, NC, USA


ISPOR Good Practices For Outcomes Research Index